Abstract: The present invention provides a method and an apparatus performing device-to-device (D2D) communication in a wireless communication system. More particularly, D2D terminals supporting D2D communication are identified, discovery groups are formed for the D2D terminals using the same application, and discovery timing is established depending on the discovery group such that D2D terminals belonging to the same discovery group are shifted to an active state during the discovery timing in order to transceive signals by using time and frequency resources designated for D2D discovery with the discovery timing having a variable value depending on the discovery group.
Type:
Grant
Filed:
October 8, 2013
Date of Patent:
March 20, 2018
Assignees:
SNU R&DB FOUNDATION, LG ELECTRONICS INC.
Inventors:
Hakseong Kim, Kwangbok Lee, Jongwoo Hong, Sunghyun Choi, Kyungsoo Kim, Seonik Seong
Abstract: The present invention relates to a core-shell nanocomposite including fluorescent bodies disposed to have a uniform distance in a perpendicular direction from a surface thereof, to a method of manufacturing same, and to a use for a probe for metal-enhanced fluorescence.
Type:
Application
Filed:
May 20, 2015
Publication date:
February 15, 2018
Applicant:
SNU R&DB FOUNDATION
Inventors:
Jwa Min NAM, Jae Ho HWANG, Min Ho KIM, Jung Hoon LEE
Abstract: Disclosed are biodegradable magnesium having a biodegradation rate which is determined by controlling an atom packing density of a surface contacting a living body, and a method for controlling the biodegradation rate of magnesium, wherein the biodegradation rate is determined by controlling an atomic packing density of the surface in contact with a living body.
Abstract: The present invention relates to a bone regeneration or bone formation promoting pharmaceutical composition comprising muramyl dipeptide, an analog thereof, a derivative thereof or a pharmaceutically acceptable salt thereof. In contrast to existing passive therapeutic agents which center on bone absorption suppression based on mechanisms for reducing osteoclast functionality, the composition comprising muramyl dipeptide of the present invention promotes the differentiation of osteoblasts, which are bone forming cells, and can advantageously be used in various diseases where bone formation is required as an active therapeutic agent that does not affect osteoclast.
Type:
Grant
Filed:
November 1, 2012
Date of Patent:
February 6, 2018
Assignee:
SNU R&DB FOUNDATION
Inventors:
Seung Hyun Han, Ok-Jin Park, Cheol-Heui Yun
Abstract: Provided is a nanoprobe based on a self-replicating biological material. The nanoprobe includes a binding agent existing in a first region of the biological material and capable of binding specifically to a target analyte, and nanoparticles existing in a second region of the biological material and providing an optical detection signal. The use of the nanoprobe enables quantitative analysis and multiplexed analysis of a target. In addition, the nanoprobe is easy to fabricate on a large scale.
Type:
Grant
Filed:
May 3, 2013
Date of Patent:
February 6, 2018
Assignee:
SNU R&DB FOUNDATION
Inventors:
Yoon-Sik Lee, Ki Tae Nam, Jun ho Chung, Dae Hong Jeong, Hye Eun Lee
Abstract: A system for collecting event data comprises: a plurality of cameras, each of which collects image data and stores the image data on a storage medium, generates data identification information including at least one information from among the group including time information on when the image data was collected, location information on where the image data was collected, and orientation information of a camera, and transmits periodically, or at a specific point of time, the data identification information via a wired or wireless network; and a service server which determines, among the plurality of cameras, at least one target camera storing image data related to a specific event by using the data identification information and event information including the time and location when and where the event has occurred, and receives image data related to the event from the target camera.
Abstract: The present disclosure relates to a technique for inhibiting biofouling of the surface of a membrane caused by a biofilm, through immobilizing biofilm formation-inhibiting microorganisms to a container in a membrane water treatment process. The present disclosure provides a non-hollow/hollow columnar or sheet-like permeable carrier with flowability owing to submerged aeration and a container with biofilm formation-inhibiting microorganisms immobilized therein, comprising biofilm formation-inhibiting microorganisms immobilized in the carrier. The present disclosure also provides a membrane water treatment apparatus comprising a reactor accommodating water to be treated, a membrane module for water treatment and a container with biofilm formation-inhibiting microorganisms immobilized therein placed in the reactor.
Abstract: A sound data processing system includes a plurality of sound collecting terminals and a server, wherein each of the plurality of sound collecting terminals and each of the plurality of sound providing terminals includes a sound collecting means that collects a sound while having a position and an orientation direction, a sound providing means that provides a sound while having an orientation direction, a position detecting means that detects the positions of the sound collecting means and the sound providing means, a direction detecting means that detects the orientation directions, and a communication module that transmits sound data corresponding to the sound collected by the sound collecting means and supplementary data including position data corresponding to the position detected by the position detecting means and orientation direction data corresponding to the orientation direction detected by the direction detecting means and through a network.
Abstract: The present invention relates to a vitamin B6-coupled poly(ester amine) (VBPEA) as a gene carrier and a method for preparing the gene carrier. Moreover, the present invention relates to a gene delivery complex comprising a therapeutic gene coupled to the gene carrier and a pharmaceutical formulation for gene therapy, which comprises the gene delivery complex as an active ingredient. In addition, the present invention relates to gene therapy utilizing the gene carrier, the gene delivery complex or the pharmaceutical formulation. The VBPEA of the invention has a significantly high gene delivery rate compared to existing gene carriers and a complex of the VBPEA with DNA has little or no cytotoxicity and shows a very high in vivo transfection efficiency. In addition, a complex of the VBPEA with siRNA shows high gene silencing efficiency and can induce a high rate of cell death and the inhibition of cell proliferation in cancer cells, suggesting that it can be used for anticancer gene therapy.
Abstract: A word embedding and word embedding apparatus are provided. The word embedding method includes receiving an input sentence, detecting an unlabeled word in the input sentence, embedding the unlabeled word based on labeled words included in the input sentence, and outputting a feature vector based on the embedding.
Type:
Application
Filed:
July 6, 2017
Publication date:
January 18, 2018
Applicants:
Samsung Electronics Co., Ltd., SNU R&DB FOUNDATION
Inventors:
Hyoungmin PARK, Kyuseok SHIM, Woo In LEE, Kyoung Gu WOO, Wonkwang SHIN
Abstract: The present invention relates to a complex in which an anti-cotinine antibody is bound to a conjugate of a binding material and cotinine, and a use of the complex. The complex according to the present invention may be used as an analysis tool in an in vitro biological assay method, and may retain the specific reactivity and the biological function of the binding material, and the capabilities of inducing complement-mediated cell cytotoxicity (CDC) and antibody-dependent cell cytotoxicity (ADCC) and a prolonged in vivo half-life, which are intrinsic characteristics of an antibody.
Type:
Grant
Filed:
April 16, 2012
Date of Patent:
January 16, 2018
Assignee:
SNU R&DB FOUNDATION
Inventors:
Junho Chung, Sunyoung Park, Do Been Hwang, Hwa Kyoung Lee
Abstract: One embodiment provides a technique of adjusting a gate voltage to be applied to at least one MOS capacitor and an amount of electric charges to be stored in the MOS capacitor so as to determine a sensitivity of a change in the amount of electric charges stored in the MOS capacitor, and exposing the MOS capacitor to an electric filed for a predetermined amount of time and then reading an electron inflow or outflow result due to the electric field so as to interpret the intensity and the direction of the electric field, thereby measuring the intensity and the direction of the electric field.
Abstract: A technique related with a lithography system is disclosed. The lithography system includes at least one target object disposed on a substrate, a processor configured to process an image of the target object to determine an optical pattern for a coating layer of the target object, and an exposure apparatus configured to provide light having the optical pattern determined by the processor to the substrate.
Abstract: Provided are a nano-structure assembly including an insulating substrate; and a nano-structure formed on the insulating substrate, and a nano-device including the same.
Abstract: A method of treating breast cancer is described, in which a peptide having cancer selective translocation function-doxoribicin conjugate is administered. The conjugate includes doxorubicin chemically linked to the N-terminus or C-terminus of a VEGF-binding protein transduction domain (VPTD) peptide represented as SEQ ID NO: 1, wherein the VPTD peptide and doxorubicin are linked to each other by a disulfide bond, and wherein the VPTD peptide binds specifically to vascular endothelial growth factor (VEGF) in tumor cells or tumor tissues.
Abstract: Provided is a denoising method including: generating a synthetic sinogram from an input original CT image; acquiring a noise component from the generated synthetic sinogram; generating a noise component CT image based on the noise component; and reducing noise in the original CT image based on the noise component CT image.
Abstract: An antenna having a broad bandwidth and a high radiation efficiency is provided. The antenna includes a conductor, and a dielectric substrate disposed on the conductor. The antenna further includes a slot portion formed on the dielectric substrate, and a cavity formed in the dielectric substrate that corresponds to the slot portion.
Type:
Grant
Filed:
November 19, 2012
Date of Patent:
December 12, 2017
Assignees:
Samsung Electronics Co., Ltd., SNU R&DB FOUNDATION
Inventors:
Jae Sup Lee, Seong Joong Kim, Sang Wook Nam, Su Min Yun
Abstract: Provided are a method for simultaneously detecting fluorescence and Raman signals for multiple fluorescence and Raman signal targets, and a medical imaging device for simultaneously detecting multiple targets using the method. The method includes: injecting at least one marker particle comprising Raman markers and receptors into the body of an animal, which can be a human; irradiating a laser beam onto the body of the animal; and detecting the optical signals emitted by the marker particle after the irradiation of the laser beam separately as fluorescence signals and Raman signals. The simultaneous detection of multiple targets may be performed even without scanning optical signals emitted by the marker particle individually with different optical fibers. As an examination may be performed by injecting surface-enhanced Raman marker particles, weak Raman signals may be augmented so as to obtain a more accurate diagnosis result in real time.
Type:
Grant
Filed:
January 4, 2017
Date of Patent:
December 5, 2017
Assignee:
SNU R&DB FOUNDATION
Inventors:
Dae Hong Jeong, Keon Wook Kang, Dong Soo Lee, Yoon Sik Lee, Gun Sung Kim, Bong Hyun Jun, Jin Chul Paeng, Ho Young Lee, Yun Sang Lee
Abstract: The present invention relates to a nanoformulated self-assembled pharmaceutical composition for photodynamic therapy. More particularly, the present invention is directed to a self-assembled pharmaceutical composition for photodynamic therapy comprising a photosensitizer, a ligand A which is separated at a specific pH range, and a ligand B of which surface charge changes at a specific pH range and a method for manufacturing the same.
Type:
Grant
Filed:
March 27, 2015
Date of Patent:
November 28, 2017
Assignees:
SNU R&DB FOUNDATION, THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC, INSTITUTE FOR BASIC SCIENCE
Inventors:
Taeghwan Hyeon, Kun Na, Daishun Ling, Wooram Park, Sin-jung Park, Yang Lu, Kyoung Sub Kim, Michael J. Hackett, Byung Hyo Kim, Hyeona Yim, Yong Sun Jeon
Abstract: Provided are a fluid for an electrowetting device including a first fluid as a polar liquid, and a second fluid, as a non-polar solution, which is separated from the first fluid by an interface, wherein the first fluid includes an organic acid having an acid dissociation constant (pKa) of about 4 or less, a polar solvent, and a quaternary ammonium hydroxide compound, and an electrowetting device including the fluid.
Type:
Grant
Filed:
April 23, 2015
Date of Patent:
November 21, 2017
Assignees:
SAMSUNG ELECTRONICS CO., LTD., SNU R&DB FOUNDATION